Journal article
Chronic antithrombotic therapy in post-myocardial infarction patients
Cardiology clinics, v 26(2), pp 277-288
01 May 2008
PMID: 18407000
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Because 1.1 million myocardial infarctions occur in the United States alone each year, and 450,000 of them are recurrent infarctions, which carry an inherently greater risk of death and disability than first events, the importance of secondary prevention strategies that can be implemented widely is unparalleled in health care. Antithrombotic therapies, both antiplatelet and anticoagulant, have become the mainstays of these strategies. This article covers the use of chronic antiplatelet and anticoagulation agents after myocardial infarction. It does not include the management of these patients in the acute phase.
Metrics
Details
- Title
- Chronic antithrombotic therapy in post-myocardial infarction patients
- Creators
- Rangadham Nagarakanti - Lankenau Institute for Medical ResearchSandeep Sodhi - Drexel UniversityRobert Lee - Ronald Reagan UCLA Medical CenterMichael Ezekowitz - Lankenau Institute for Medical Research
- Publication Details
- Cardiology clinics, v 26(2), pp 277-288
- Publisher
- Elsevier
- Number of pages
- 13
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Creative Arts Therapies
- Web of Science ID
- WOS:000255796000012
- Scopus ID
- 2-s2.0-41949096470
- Other Identifier
- 991019167780504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Cardiac & Cardiovascular Systems